Fundraising FoxCornucopian Capital Management — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor.
BiotechDeep TechFoodTechSeattle, US
Eric Steven Quick(Executive Officer, Director)Aryeh Ganz(Executive Officer, Director, Promoter)
BoardFrank Curzio(Director)
Co-investorsBaruch Future Ventures
Ilant Health provides value-based care for obesity and cardiometabolic disease, combining anti-obesity medications, bariatric procedures, behavioral change, and support from clinicians, dietitians, care navigators, and mental health professionals.
AI & Machine LearningDigital HealthHealthtechWellness & FitnessClaymont, US
Elina Onitskansky(Executive Officer, Director, Promoter)in
BoardAryeh Ganz(Director)Matthew Klitus(Director)
Co-investorsCeltic House Asia PartnersCity LightLifeX VenturesnaturalX Health VenturesPeakBridge VCInnovation Works
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.